What You Should Know
- The Alliance: Havas Health has announced an exclusive, strategic partnership with BrightInsight, designating the firm as its single global agency partner for digital persistence and adherence solutions.
- The Core Problem: The pharmaceutical industry loses an estimated $500 billion annually because patients fail to adhere to or persist with their prescribed therapies.
- The Technology: BrightInsight brings a pre-vetted, regulatory-compliant digital health platform (powering companion apps and Software as a Medical Device) that operates across more than 60 countries.
- The Proven Impact: The BrightInsight platform has demonstrated the ability to reduce long-term therapy discontinuation by four percentage points and increase adherence by another four percentage points compared to traditional patient support programs.
Merging Strategy with “Always-On” Infrastructure
Historically, pharmaceutical marketing agencies focused strictly on the top of the funnel: driving awareness and getting the initial prescription written. Patient support was often relegated to static brochures or rudimentary call centers.
This partnership signals a fundamental shift. By integrating BrightInsight’s AI-enabled, regulatory-ready platform into its core offering, Havas Health is moving beyond traditional communications and into active disease management. BrightInsight provides the underlying cloud architecture for digital-first patient support programs (PSPs), companion apps, and Software as a Medical Device (SaMD).
Instead of starting from scratch, biopharma brands can now leverage a standardized, configurable infrastructure that tracks patient progress, delivers personalized interventions, and flags potential drop-offs before they happen.
Overcoming the Regulatory Bottleneck
The biggest hurdle to scaling digital health solutions globally is the patchwork of international privacy and medical device regulations. A companion app that is compliant in the United States might violate data residency laws in Europe. BrightInsight solves this scaling problem. Its platform is built to support regulated digital health across more than 60 countries.
“Our clients are no longer asking if they should go digital, but how they can do so without reinventing the wheel for every market and every brand,” said Jeff Hoffman, Chief Development Officer, Havas Health Network. “By integrating BrightInsight’s platform into our core offering, Havas Health is moving beyond traditional communications. We are now providing our clients with a pre-vetted, regulatory-ready engine that ensures a patient’s experience with a brand is as meaningful and reliable as the therapy itself. That’s where long-term value and impact are truly realized.”
